SecBot SecBot
SECBOTREPLAY Home › Report › TXG

TXG · Three corporate insiders at 10x Genomics, Inc

10x Genomics, Inc. · CLUSTER filed Feb 22, 2026 at 19:00 ET

At the news

BEARISHIMPACT 6/10

CLUSTER filed Feb 22, 2026 at 19:00 ET

Three corporate insiders at 10x Genomics, Inc. (TXG), including the CEO and CFO, sold shares in a coordinated open-market transaction on February 23, 2026, collectively disposing of 26,426 shares for approximately $490,900. The sales were executed at the same price, indicating a planned divestment, which may signal reduced confidence in near-term stock performance.

  • CEO Serge Saxonov sold 9,632 shares for $178,928 in open-market transaction.
  • CFO Adam Taich sold 8,968 shares for $166,593 in open-market transaction.
  • Benjamin J. Hindson (former CEO, now listed as 'See Remarks') sold 7,826 shares for $145,379.
  • All three sales occurred on the same day at identical price of $18.5764 per share.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access